Massa I - Search Results

1

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy.

Ravaioli S, Tumedei MM, Foca F, Maltoni R, Rocca A, Massa I, Pietri E, Bravaccini S. Ravaioli S, et al. Among authors: massa i. Int J Exp Pathol. 2017 Oct;98(5):289-295. doi: 10.1111/iep.12253. Epub 2017 Nov 28. Int J Exp Pathol. 2017. PMID: 29193395 Free PMC article.

2

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience.

Passardi A, Massa I, Zoli W, Gianni L, Milandri C, Zumaglini F, Nanni O, Maltoni R, Frassineti GL, Amadori D. Passardi A, et al. Among authors: massa i. BMC Cancer. 2006 Mar 21;6:76. doi: 10.1186/1471-2407-6-76. BMC Cancer. 2006. PMID: 16551351 Free PMC article. Clinical Trial.

3

A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.

Rocca A, Maltoni R, Passardi A, Massa I, Aquilina M, Ridolfi R, Ibrahim T, Cecconetto L, Sarti S, Pietri E, Nanni O, Amadori D. Rocca A, et al. Among authors: massa i. Cancer Chemother Pharmacol. 2010 Apr;65(5):871-6. doi: 10.1007/s00280-009-1092-8. Epub 2009 Aug 20. Cancer Chemother Pharmacol. 2010. PMID: 19693503 Clinical Trial.

4

Uncovering the genomic heterogeneity of multifocal breast cancer.

Desmedt C, Fumagalli D, Pietri E, Zoppoli G, Brown D, Nik-Zainal S, Gundem G, Rothé F, Majjaj S, Garuti A, Carminati E, Loi S, Van Brussel T, Boeckx B, Maetens M, Mudie L, Vincent D, Kheddoumi N, Serra L, Massa I, Ballestrero A, Amadori D, Salgado R, de Wind A, Lambrechts D, Piccart M, Larsimont D, Campbell PJ, Sotiriou C. Desmedt C, et al. Among authors: massa i. J Pathol. 2015 Aug;236(4):457-66. doi: 10.1002/path.4540. Epub 2015 May 7. J Pathol. 2015. PMID: 25850943 Free PMC article.

5

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast.

Tumedei MM, Silvestrini R, Ravaioli S, Massa I, Maltoni R, Rocca A, Folli S, Buggi F, Curcio A, Serra L, Puccetti M, Amadori D, Bravaccini S. Tumedei MM, et al. Among authors: massa i. Int J Biol Markers. 2015 Nov 11;30(4):e425-8. doi: 10.5301/jbm.5000163. Int J Biol Markers. 2015. PMID: 26165687 Free article.

6

Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study.

Massa I, Nanni O, Guidoboni M, Frassineti GL, Rocca A, Burgio MA, Valmorri L, Marri M, Piancastelli A, Faedi M, Leoni M, Tamberi S, Altini M, Amadori D. Massa I, et al. Oncol Lett. 2016 Jan;11(1):831-836. doi: 10.3892/ol.2015.3967. Epub 2015 Nov 24. Oncol Lett. 2016. PMID: 26870292 Free PMC article.

7

Androgen receptor signaling pathways as a target for breast cancer treatment.

Pietri E, Conteduca V, Andreis D, Massa I, Melegari E, Sarti S, Cecconetto L, Schirone A, Bravaccini S, Serra P, Fedeli A, Maltoni R, Amadori D, De Giorgi U, Rocca A. Pietri E, et al. Among authors: massa i. Endocr Relat Cancer. 2016 Oct;23(10):R485-98. doi: 10.1530/ERC-16-0190. Epub 2016 Aug 15. Endocr Relat Cancer. 2016. PMID: 27528625 Review.

8

Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte.

Campi B, Frascarelli S, Pietri E, Massa I, Donati C, Bozic R, Bertelloni S, Paolicchi A, Zucchi R, Saba A. Campi B, et al. Among authors: massa i. Anal Bioanal Chem. 2018 Jan;410(2):407-416. doi: 10.1007/s00216-017-0731-x. Epub 2017 Nov 6. Anal Bioanal Chem. 2018. PMID: 29110028

9

The challenge of sustainability in healthcare systems: frequency and cost of diagnostic procedures in end-of-life cancer patients.

Massa I, Balzi W, Altini M, Bertè R, Bosco M, Cassinelli D, Vignola V, Cavanna L, Foca F, Dall'Agata M, Nanni O, Rossi R, Maltoni M. Massa I, et al. Support Care Cancer. 2018 Jul;26(7):2201-2208. doi: 10.1007/s00520-018-4067-7. Epub 2018 Feb 1. Support Care Cancer. 2018. PMID: 29387995 Free PMC article.

10

Chemotherapy and palliative care near end-of life: examining the appropriateness at a cancer institute for colorectal cancer patients.

Massa I, Nanni O, Foca F, Maltoni M, Derni S, Gentili N, Frassineti GL, Casadei Gardini A, Valgiusti M, Amadori D, Prati E, Altini M, Gallegati D, Sansoni E. Massa I, et al. BMC Palliat Care. 2018 Jun 19;17(1):86. doi: 10.1186/s12904-018-0339-8. BMC Palliat Care. 2018. PMID: 29914452 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters